GGrantIndex
← Leaderboards

James William Mandell

University Of Virginia Charlottesville

$3,402,487
Attributed
$3,402,487
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.6M · FY200516
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$17,483,758 · 7

By mechanism

M01$14,081,271 · 1
R21$1,582,414 · 4
R01$1,494,183 · 1
K02$325,890 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Astrocytes

Research focus

AstrocytesTissue /Cell CultureLaboratory MouseComplexCellsMitogen Activated Protein KinaseTransfectionBiological Signal TransductionTraumaInjuryHuman SubjectMolecularClinical ResearchBrainImmunocytochemistryIn VivoNerve InjuryPathway InteractionsCell TypeResponseGenetically Modified AnimalsNatural RegenerationInsightApoptotic

Grant awards (26)

Circulating Non-coding RNAs as Biomarkers of Inclusion Body Myositis$173,800
R21 · FY2016 · AR · contact PI
Circulating Non-coding RNAs as Biomarkers of Inclusion Body Myositis$208,560
R21 · FY2015 · AR · contact PI
Global Identification of Mammalian Synaptic Caspase Targets$185,763
R21 · FY2013 · NS · contact PI
Global Identification of Mammalian Synaptic Caspase Targets$231,000
R21 · FY2012 · NS · contact PI
Astroglial Phagocytosis of Degenerating Neurons and Axons: Role of Rac1 and ELMO1$187,481
R21 · FY2010 · NS · contact PI
Astroglial Phagocytosis of Degenerating Neurons and Axons: Role of Rac1 and ELMO1$227,250
R21 · FY2009 · NS · contact PI
Functions of ERK and p38 MAP Kinases in Astrogliosis$267,506
R01 · FY2008 · NS · contact PI
General Clinical Research Center$1
M01 · FY2008 · RR · contact PI
General Clinical Research Center$2,231,648
M01 · FY2007 · RR · contact PI
Functions of ERK and p38 MAP Kinases in Astrogliosis$292,389
R01 · FY2007 · NS · contact PI
General Clinical Research Center$2,231,357
M01 · FY2006 · RR · contact PI
Functions of ERK and p38 MAP Kinases in Astrogliosis$319,428
R01 · FY2006 · NS · contact PI
General Clinical Research Center$2,306,807
M01 · FY2005 · RR
Functions of ERK and p38 MAP Kinases in Astrogliosis$281,586
R01 · FY2005 · NS
Functions of ERK and p38 MAP Kinases in Astrogliosis$18,747
R01 · FY2005 · NS
General Clinical Research Center$1,831,058
M01 · FY2004 · RR
Functions of ERK and p38 MAP Kinases in Astrogliosis$314,527
R01 · FY2004 · NS
GENERAL CLINICAL RESEARCH CENTER$2,323,346
M01 · FY2003 · RR
Hypoglycemic signaling targets in astrocytes$185,000
R21 · FY2003 · NS
MAP KINASE SIGNALING IN ASTROGLIAL REACTIONS$99,630
K02 · FY2003 · NS
GENERAL CLINICAL RESEARCH CENTER$1,424,472
M01 · FY2002 · RR
Hypoglycemic signaling targets in astrocytes$183,560
R21 · FY2002 · NS
GENERAL CLINICAL RESEARCH CENTER$1,685,120
M01 · FY2001 · RR
MAP KINASE SIGNALING IN ASTROGLIAL REACTIONS$99,630
K02 · FY2001 · NS
GCRC-CAP-CATHERINE GORDON, M.D. (ADDITIONAL TIME)$47,462
M01 · FY2001 · RR
MAP KINASE SIGNALING IN ASTROGLIAL REACTIONS$126,630
K02 · FY2000 · NS